Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Berlin - Delayed Quote EUR

Sutro Biopharma Inc (S09.BE)

Compare
1.7100
-0.0500
(-2.84%)
At close: February 21 at 8:13:04 AM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
160,955
153,731
67,772
61,880
42,722
Operating Expense
290,998
243,009
196,715
160,404
113,779
Operating Income
-130,043
-89,278
-128,943
-98,524
-71,057
Net Non Operating Interest Income Expense
14,011
-9,240
109
-2,560
-2,466
Other Income Expense
--
9,917
12,130
-4,454
41,498
Pretax Income
-108,138
-88,601
-116,704
-105,538
-32,025
Tax Provision
15,815
18,192
2,500
--
103
Net Income Common Stockholders
-123,953
-106,793
-119,204
-105,538
-32,128
Diluted NI Available to Com Stockholders
-123,953
-106,793
-119,204
-105,538
-32,128
Basic EPS
-1.55
-1.78
-2.35
-2.29
-0.99
Diluted EPS
-1.55
-1.78
-2.35
-2.29
-0.99
Basic Average Shares
71,443.9590
60,163.5420
50,739.1850
46,119.0890
32,573.4690
Diluted Average Shares
71,443.9590
60,163.5420
50,739.1850
46,119.0890
32,573.4690
Total Operating Income as Reported
-130,043
-89,278
-128,943
-98,524
-71,057
Total Expenses
290,998
243,009
196,715
160,404
113,779
Net Income from Continuing & Discontinued Operation
-123,953
-106,793
-119,204
-105,538
-32,128
Normalized Income
-130,189.2600
-114,627.4300
-128,786.7000
-101,084
-62,421.5400
Interest Income
45,123
14,510
3,455
577
1,508
Interest Expense
31,112
23,750
3,346
3,137
3,974
Net Interest Income
14,011
-9,240
109
-2,560
-2,466
EBIT
-77,026
-64,851
-113,358
-102,401
-28,051
EBITDA
-69,945
-58,035
-107,668
-97,557
-23,754
Reconciled Depreciation
7,081
6,816
5,690
4,844
4,297
Net Income from Continuing Operation Net Minority Interest
-123,953
-106,793
-119,204
-105,538
-32,128
Total Unusual Items Excluding Goodwill
7,894
9,917
12,130
-4,454
41,498
Total Unusual Items
7,894
9,917
12,130
-4,454
41,498
Normalized EBITDA
-77,839
-67,952
-119,798
-93,103
-65,252
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
0.0003
Tax Effect of Unusual Items
1,657.7400
2,082.5700
2,547.3000
--
11,204.4600
12/31/2020 - 2/20/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

W2J.BE CARISMA Therapeutics Inc
0.4454
+2.96%
 
W2J.DU Carisma Therapeutics Inc. R
0.4218
+0.09%
 
37Z.BE Allakos Inc
0.2700
-1.35%
 
W2J.F Carisma Therapeutics, Inc.
0.4522
+2.49%
 
8AW0.BE Ocean Biomedical Inc
0.1220
-6.15%
 
8AW0.MU Ocean Biomedical Inc
0.1330
-1.48%
 
8AW0.SG Ocean Biomedical Inc
0.1210
+12.04%
 
W2J.MU CARISMA Therapeutics Inc
0.4484
-2.22%
 
W2J.SG CARISMA Therapeutics Inc
0.4214
+0.10%
 
8AW0.F Ocean Biomedical, Inc.
0.1200
-4.76%